Moreover, correlation analysis indicated that miR-320e could be a better biomarker for CHD diagnosis compared to most conventional clinical factors, such as apolipoprotein A (ApoA), apolipoprotein B (ApoB), and LPA 54. Here, APOB is linked to coronary artery disorder.